Hamilton Lane (NASDAQ:HLNE) Price Target Raised to $161.00 at Keefe, Bruyette & Woods

Hamilton Lane (NASDAQ:HLNE) had its price target hoisted by Keefe, Bruyette & Woods from $158.00 to $161.00 in a research note published on Wednesday,Benzinga reports. They currently have an outperform rating on the stock.

Several other brokerages have also issued reports on HLNE. Weiss Ratings lowered Hamilton Lane from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Saturday, October 25th. Oppenheimer set a $181.00 price objective on shares of Hamilton Lane and gave the stock an “outperform” rating in a report on Tuesday, October 14th. Wall Street Zen raised shares of Hamilton Lane from a “sell” rating to a “hold” rating in a research note on Sunday, November 9th. Morgan Stanley reduced their target price on shares of Hamilton Lane from $169.00 to $154.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 21st. Finally, The Goldman Sachs Group raised shares of Hamilton Lane from a “neutral” rating to a “buy” rating and set a $165.00 price target for the company in a research note on Thursday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $160.50.

Hamilton Lane Stock Up 0.0%

HLNE opened at $131.90 on Wednesday. The business’s fifty day simple moving average is $123.81 and its 200 day simple moving average is $139.30. Hamilton Lane has a 52 week low of $111.98 and a 52 week high of $179.19. The company has a quick ratio of 3.49, a current ratio of 3.49 and a debt-to-equity ratio of 0.25. The stock has a market cap of $7.36 billion, a PE ratio of 23.90 and a beta of 1.33.

Hamilton Lane (NASDAQ:HLNE) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.46. The firm had revenue of $190.88 million during the quarter, compared to analysts’ expectations of $171.86 million. Hamilton Lane had a return on equity of 29.43% and a net margin of 31.12%. As a group, research analysts expect that Hamilton Lane will post 4.97 earnings per share for the current fiscal year.

Hamilton Lane Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Friday, December 19th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Friday, December 19th. Hamilton Lane’s dividend payout ratio is currently 39.13%.

Insiders Place Their Bets

In other news, CEO Juan Delgado-Moreira purchased 8,000 shares of the business’s stock in a transaction on Friday, November 7th. The shares were acquired at an average price of $130.35 per share, with a total value of $1,042,800.00. Following the acquisition, the chief executive officer directly owned 1,314,447 shares in the company, valued at approximately $171,338,166.45. The trade was a 0.61% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 22.21% of the stock is owned by insiders.

Hedge Funds Weigh In On Hamilton Lane

Hedge funds and other institutional investors have recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC bought a new stake in shares of Hamilton Lane in the first quarter worth about $432,772,000. Wellington Management Group LLP lifted its holdings in Hamilton Lane by 5.5% in the 1st quarter. Wellington Management Group LLP now owns 1,701,963 shares of the company’s stock worth $253,031,000 after buying an additional 88,100 shares during the period. Invesco Ltd. lifted its holdings in Hamilton Lane by 7.3% in the 3rd quarter. Invesco Ltd. now owns 1,534,836 shares of the company’s stock worth $206,880,000 after buying an additional 104,977 shares during the period. Champlain Investment Partners LLC grew its position in shares of Hamilton Lane by 33.8% in the 3rd quarter. Champlain Investment Partners LLC now owns 1,388,380 shares of the company’s stock worth $187,140,000 after buying an additional 350,437 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Hamilton Lane by 5.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,368,373 shares of the company’s stock worth $203,437,000 after buying an additional 76,107 shares during the last quarter. 97.40% of the stock is owned by institutional investors.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.